000 01887 a2200505 4500
005 20250516140300.0
264 0 _c20131126
008 201311s 0 0 eng d
022 _a1090-2430
024 7 _a10.1016/j.expneurol.2013.02.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKuypers, Nicholas J
245 0 0 _aFunctional consequences of ethidium bromide demyelination of the mouse ventral spinal cord.
_h[electronic resource]
260 _bExperimental neurology
_cSep 2013
300 _a615-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDemyelinating Diseases
_xchemically induced
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xtoxicity
650 0 4 _aEthidium
_xtoxicity
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aGlial Fibrillary Acidic Protein
_xmetabolism
650 0 4 _aHindlimb
_xphysiopathology
650 0 4 _aLeukocyte Common Antigens
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMicroscopy, Electron, Transmission
650 0 4 _aMotor Activity
650 0 4 _aNerve Fibers, Myelinated
_xpathology
650 0 4 _aNeurofilament Proteins
_xmetabolism
650 0 4 _aRecovery of Function
_xphysiology
650 0 4 _aSeverity of Illness Index
650 0 4 _aSpinal Cord
_xpathology
650 0 4 _aSpinal Cord Injuries
_xchemically induced
650 0 4 _aTime Factors
700 1 _aJames, Kurtis T
700 1 _aEnzmann, Gaby U
700 1 _aMagnuson, David S K
700 1 _aWhittemore, Scott R
773 0 _tExperimental neurology
_gvol. 247
_gp. 615-22
856 4 0 _uhttps://doi.org/10.1016/j.expneurol.2013.02.014
_zAvailable from publisher's website
999 _c22559260
_d22559260